IMM-101, an immunotherapeutic agent in clinical development as an adjunctive treatment for pancreatic cancer. (6th November 2014) - Bilyard, Hilary; Mines, Charlotte; Brunet, Laura Rosa; Dalgleish, Angus; Macintosh, Frances